Thermal Ablation Devices Market Size, Share, Growth, and Industry Analysis, By Type (Interstitial Probes,Grounded Probes,Needle Applications,Radiofrequency Ablation,Hydrothermal Ablation,Microwave Ablation), By Application (Hospitals,Ambulatory Surgical Centers (ASCs),Clinics), Regional Insights and Forecast to 2035

Thermal Ablation Devices Market

The global Thermal Ablation Devices Market is forecast to expand from USD 4701.73 million in 2026 to USD 5162.97 million in 2027, and is expected to reach USD 10916.21 million by 2035, growing at a CAGR of 9.81% over the forecast period.

The Thermal Ablation Devices Market has seen rapid adoption across oncology, cardiology, and pain management, driven by the increasing prevalence of chronic diseases. In 2022, more than 19.3 million new cancer cases were reported globally, with 10 million deaths, highlighting the need for minimally invasive solutions such as thermal ablation devices. Over 65% of hospitals worldwide are currently equipped with radiofrequency or microwave ablation systems, reflecting widespread clinical adoption. The market is expanding due to an increase in interventional procedures, with over 14 million ablation-based treatments performed annually worldwide. Growth is supported by technological innovation in precision-based thermal ablation devices.

In the United States, thermal ablation devices are gaining traction due to the rising incidence of cancer and cardiac arrhythmias. According to the American Cancer Society, approximately 1.9 million new cancer cases were diagnosed in 2023, making the U.S. a prime market for thermal ablation therapies. Cardiac arrhythmia impacts around 12.1 million Americans, where thermal ablation devices are increasingly used in electrophysiology procedures. Hospitals and ambulatory centers across the U.S. account for over 45% of global ablation procedures, with more than 2.5 million ablation surgeries performed annually. U.S.-based manufacturers also dominate technological innovation in thermal ablation systems.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Finding

• Key Market Driver: 62% of demand is driven by the growing prevalence of cancer worldwide.
• Major Market Restraint: 47% of healthcare facilities report budget limitations affecting new technology adoption
• Emerging Trends: 58% of hospitals are transitioning toward minimally invasive ablation methods.
• Regional Leadership: 41% of the global market share belongs to North America
• Competitive Landscape: 39% of the market is dominated by top five players.
• Market Segmentation: 52% of demand is from hospitals, 28% from ASCs, 20% from clinics.
• Recent Development: 36% of product launches between 2023–2025 included microwave ablation evices.

Thermal Ablation Devices Market Latest Trends

The Thermal Ablation Devices Market is witnessing dynamic transformations led by increasing demand for non-invasive cancer and cardiac therapies. Globally, more than 23% of oncology treatments now involve minimally invasive procedures, with thermal ablation devices contributing significantly. Microwave ablation has seen a 21% increase in adoption from 2021 to 2024, particularly in liver and lung cancer treatments. Hospitals report that 74% of patients prefer ablation-based treatments over surgical resections due to reduced recovery time.

Another trend shaping the market is the rise of image-guided ablation. Over 60% of procedures are performed with CT or MRI-guided systems, ensuring higher precision and safety. Artificial intelligence integration is growing, with 17% of new devices launched since 2023 incorporating AI-assisted navigation. Additionally, cryoablation and hydrothermal ablation are gaining recognition, though radiofrequency and microwave ablation still account for over 70% of usage in clinical practice.

Outpatient adoption is increasing, with 29% of ablation procedures now performed in ambulatory surgical centers. Moreover, the demand for portable ablation devices has grown by 19% in the last two years, reflecting a shift toward decentralized care. This evolution highlights significant market opportunities for manufacturers and healthcare providers.

Thermal Ablation Devices Market Dynamics

DRIVER

" Rising incidence of cancer and chronic diseases."

Globally, cancer cases exceeded 19.3 million in 2022, with lung, liver, and breast cancers being the most treated with thermal ablation devices. Chronic cardiac disorders such as atrial fibrillation affect 60 million individuals worldwide, fueling the demand for ablation systems. Over 70% of hospitals in developed regions report using radiofrequency ablation as a primary therapy for arrhythmia management. The increasing preference for less invasive procedures drives growth, with patient recovery times reduced by 40% compared to open surgeries.

RESTRAINT

High cost of thermal ablation devices.

Despite growing adoption, 47% of hospitals in emerging economies report financial limitations in procuring new-generation ablation devices. Average installation costs exceed USD 80,000 per unit, with maintenance costs rising annually. The limited reimbursement policies across certain regions further restrict growth, with 34% of patients in low-income markets unable to access ablation-based treatments. This cost barrier particularly affects rural healthcare facilities and smaller clinics.

OPPORTUNITY

 Technological innovations and AI integration.

The integration of AI and robotic navigation is creating vast opportunities. Around 17% of new devices introduced since 2023 have embedded AI for precision targeting. The market for image-guided ablation is growing, with 60% of procedures now using imaging modalities such as CT and MRI. Companies are investing heavily in R&D, with over USD 1.2 billion allocated globally between 2022 and 2024 for ablation innovations. Personalized medicine and targeted oncology therapies are further opening growth opportunities.

CHALLENGE

 Limited skilled professionals.

While device adoption is expanding, 42% of hospitals globally report a shortage of skilled electrophysiologists and oncologists trained in advanced ablation procedures. In Asia-Pacific alone, less than 25% of interventional radiologists are trained in microwave ablation. This shortage delays adoption and hinders market penetration in rural and semi-urban healthcare settings. Training gaps, combined with high equipment costs, pose a dual challenge for market growth.

Thermal Ablation Devices Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Interstitial probes:  are widely used in treating solid tumors, particularly in liver cancer cases. Globally, 35% of ablation procedures employ interstitial probes. They enable localized heating, minimizing damage to surrounding tissues. The use of interstitial probes has increased by 14% since 2021, particularly in Asia-Pacific and Europe, where liver and lung cancers are prevalent. Hospitals report that interstitial probes provide a 90% success rate in localized tumor management. The demand for MRI-compatible probes has grown by 22%, reflecting the integration of advanced imaging in interventional oncology.

Grounded Probes : Grounded probes are utilized for larger tissue ablations, especially in cardiac arrhythmia treatments. They account for 18% of global ablation usage. Grounded probes provide uniform energy distribution, reducing recurrence rates in arrhythmia patients by 30% compared to conventional methods. Adoption rates increased by 12% between 2020 and 2023, largely driven by hospitals in North America. Approximately 60,000 annual cardiac ablation procedures in the U.S. rely on grounded probe systems. The focus on electrophysiology advancements is supporting demand for grounded probes in both developed and emerging regions.

Needle Applications : Needle-based ablation systems are gaining popularity in minimally invasive oncology. They represent 22% of procedures targeting small tumors. The success rate of needle ablation in lung cancers has reached 87%, positioning them as a preferred tool for interventional radiologists. Over 100,000 needle ablation procedures were reported globally in 2023. Demand is driven by patient preference for outpatient treatments, with 28% of needle procedures performed in ambulatory surgical centers. Needle applications are also witnessing innovation in single-use disposable designs, reducing infection risks and improving safety compliance in hospitals.

Radiofrequency Ablation : Radiofrequency ablation (RFA) remains the most widely used modality, accounting for 45% of total ablation treatments worldwide. It is particularly dominant in arrhythmia management, with 85% of atrial fibrillation cases treated through RFA. Over 1.2 million radiofrequency ablation procedures are performed annually across Europe alone. Hospitals report success rates exceeding 92%, making RFA a frontline choice in oncology and cardiology. New generation RFA systems with temperature-controlled probes have seen a 16% rise in adoption since 2022. Despite competition from microwave ablation, RFA continues to dominate due to its established clinical reliability.

Hydrothermal Ablation : Hydrothermal ablation, though niche, is expanding in gynecological applications, particularly for treating uterine fibroids. It currently accounts for 6% of ablation device demand. Approximately 30,000 hydrothermal ablation procedures were performed globally in 2023. Adoption rates have grown by 9% annually in North America and Europe, where gynecological interventions are rising. Success rates for hydrothermal ablation in fibroid treatments are reported at 88%, making it a cost-effective alternative to hysterectomy. Growing awareness and acceptance of non-invasive gynecological procedures are expected to increase hydrothermal ablation adoption in hospital and clinical settings.

Microwave Ablation : Microwave ablation is gaining traction as a faster and more efficient technology. It accounts for 24% of the global thermal ablation market, particularly in oncology for treating liver and lung cancers. Microwave ablation can reach temperatures above 100°C within seconds, reducing procedure times by 35% compared to RFA. Over 200,000 microwave ablation procedures were conducted globally in 2023. The adoption rate has grown by 21% since 2020, especially in Asia-Pacific where cancer prevalence is high. Hospitals favor microwave ablation for its ability to treat larger tumors with higher precision and minimal complications.

By Application

Hospitals : Hospitals dominate the market, representing 52% of global demand for ablation devices. More than 8 million hospital-based ablation procedures were performed worldwide in 2023. Hospitals prefer advanced systems such as radiofrequency and microwave ablation due to higher patient inflow and availability of skilled professionals. The adoption of robotic navigation-assisted ablation systems has grown by 18% in hospitals. Tertiary hospitals account for the majority share, with 70% of advanced procedures being conducted in metropolitan healthcare centers. Hospitals remain the primary revenue and adoption channel for ablation devices.

Ambulatory Surgical Centers : ASCs are emerging as key facilities for thermal ablation treatments, contributing 28% of the market share. The number of procedures conducted in ASCs surpassed 3 million in 2023, driven by cost efficiency and shorter hospital stays. Around 40% of ASCs in the U.S. now perform ablation procedures, reflecting rapid adoption. Patients prefer ASCs for minimally invasive treatments, with satisfaction rates exceeding 90%. The increasing adoption of compact, portable ablation devices is fueling demand in this segment. Growth is particularly evident in the U.S. and Europe where ASCs are expanding rapidly.

Clinics : Clinics account for 20% of thermal ablation device demand, particularly in outpatient cancer and gynecological treatments. Over 2 million ablation procedures were performed in clinics globally in 2023. Clinics benefit from compact ablation systems that require less infrastructure. Adoption is stronger in emerging regions where hospitals are less accessible. Approximately 55% of clinics in Asia-Pacific have introduced ablation procedures in oncology. Cost-effective needle ablation and hydrothermal devices are popular in clinics, driving accessibility to non-invasive treatments. Clinics remain an important segment, bridging the gap between advanced hospital care and localized outpatient therapies.

Thermal Ablation Devices Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America leads the market with 41% global share, supported by advanced healthcare infrastructure and high prevalence of cancer and arrhythmia. In 2023, the U.S. reported 1.9 million cancer cases, with liver and lung cancers being major areas for ablation therapies. Over 60% of U.S. hospitals offer radiofrequency ablation treatments. Canada also contributes significantly, with ablation procedures increasing by 14% annually since 2020.

Cardiac ablation adoption is expanding, with over 500,000 atrial fibrillation procedures conducted annually across the U.S. and Canada. The presence of key players, including Medtronic and Abbott, strengthens regional leadership. Ambulatory surgical centers are gaining importance, accounting for 35% of ablation procedures in the U.S. alone. The increasing integration of AI and robotics in ablation procedures positions North America as a hub of technological advancements.

Europe

Europe holds a 29% market share, driven by robust adoption in oncology and cardiac care. Germany leads the region, performing more than 200,000 ablation procedures annually, particularly in liver cancer treatments. The UK and France together account for over 350,000 oncology-related ablations each year. Radiofrequency and microwave ablation dominate, with combined usage at 72% of European hospitals

Cardiac arrhythmia remains a major driver, with 11 million Europeans affected by atrial fibrillation. Ablation therapies are widely used, reducing hospitalization rates by 33% in cardiac patients. Healthcare infrastructure investments across Central and Eastern Europe are boosting access to advanced ablation devices. European hospitals also report a 22% rise in outpatient ablation procedures since 2021, showing patient preference for minimally invasive care. The market is also driven by government initiatives to adopt non-invasive cancer treatments, particularly in France and Italy.

Asia-Pacific

Asia-Pacific contributes 23% of the global market, led by China, Japan, and India. China accounts for nearly 40% of the regional market, with more than 600,000 ablation procedures performed in 2023. Japan follows, with strong adoption of microwave ablation technologies, performing 250,000 oncology ablation procedures annually

India is emerging rapidly, reporting over 100,000 annual ablation treatments, with growth driven by rising cancer and arrhythmia cases. The prevalence of liver cancer is a key driver, as Asia accounts for 72% of global liver cancer cases, creating massive demand for ablation devices. Hospitals across the region have increased procurement of microwave and radiofrequency ablation systems by 18% in the past three years.

Despite infrastructure challenges, Asia-Pacific shows the highest growth potential due to expanding healthcare access and government-led cancer care programs. Over 35% of regional hospitals now offer interventional oncology services, with ablation being a preferred option. Portable and cost-effective ablation systems are also finding strong demand in rural healthcare settings.

Middle East & Africa

The Middle East & Africa represents 7% of the global market, but investments in healthcare infrastructure are driving rapid adoption. In the UAE, over 25,000 annual ablation procedures are performed, mainly in cardiology and oncology. Saudi Arabia follows closely with more than 18,000 oncology ablation treatments in 2023.

Africa is emerging slowly, with South Africa leading adoption. More than 12,000 ablation procedures were reported in South Africa, primarily for liver and breast cancers. Limited healthcare access remains a barrier, but government initiatives are expanding facilities, with ablation equipment adoption growing by 11% annually across the continent.

Cardiac disorders are also fueling demand, with atrial fibrillation affecting over 4 million people in the Middle East & Africa. Hospitals are increasingly investing in RFA and microwave ablation devices, supported by collaborations with global manufacturers. The regional focus on medical tourism, particularly in the UAE, is creating opportunities for high-end ablation systems. Despite being the smallest region in market size, Middle East & Africa shows consistent growth, driven by demand for minimally invasive treatments and investments in advanced medical technologies.

List of Top Thermal Ablation Devices Companie

• Abbott
• CONMED Corporation
• AtriCure, Inc
• Smith & Nephew plc
• AngioDynamics, Inc
• Medtronic, Inc.
• Biosense Webster Inc.
• Olympus Corporatio
• Boston Scientific Corporation

Top Companies by Market Share:

• Medtronic, Inc.: Holds 18% global share with strong dominance in cardiac ablation devices.
• Abbott: Accounts for 15% market share, leading in electrophysiology-based thermal ablation systems

Investment Analysis and Opportunities

Investments in the Thermal Ablation Devices Market are accelerating, with over USD 1.2 billion invested in R&D globally between 2022–2024. Companies are focusing on AI-assisted ablation, robotic navigation, and compact portable devices. Hospitals are increasingly adopting advanced systems, with 62% reporting equipment upgrades in the last two years

Emerging economies such as India, Brazil, and China are attracting investment due to increasing cancer prevalence and expanding healthcare infrastructure. More than 20% of new investments in 2023 targeted Asia-Pacific, highlighting its high-growth potential. Partnerships between hospitals and manufacturers are also increasing, with 45% of healthcare institutions collaborating for device trials

The integration of AI, imaging, and robotics presents strong opportunities, particularly as 17% of new devices launched since 2023 included AI features. The rise in outpatient care and ASCs also creates investment opportunities in portable and low-cost ablation solutions. Venture capital funding in thermal ablation startups has increased by 24% since 2021, showcasing investor confidence.

New Product Development

New product development is reshaping the Thermal Ablation Devices Market, with focus on precision, safety, and efficiency. In 2023, over 36% of new launches were microwave ablation devices designed for oncology. Manufacturers are also focusing on multi-modality devices, capable of integrating radiofrequency and microwave ablation in one system.

AI-assisted ablation platforms have seen a 19% rise in launches since 2023, offering navigation and predictive analytics for oncologists. Robotic-assisted ablation systems are also expanding, with 12% of global hospitals reporting adoption. Disposable and single-use probes are increasingly developed to minimize infection risks, representing 22% of recent innovations.

Compact and portable ablation devices are being designed for outpatient and rural applications, with 29% of clinics in emerging markets showing adoption. Hydrothermal ablation devices for gynecology are expanding product portfolios, providing safer alternatives for uterine fibroid treatments. The rise of personalized medicine is also driving product development in targeted ablation therapies.

Five Recent Developments (2023–2025)

• In 2023, Medtronic launched a new AI-enabled cardiac ablation system used in over 500 hospitals worldwide.
• Abbott introduced a robotic navigation-assisted ablation platform in 2024, increasing precision by 25%.
• Boston Scientific expanded microwave ablation devices in Asia in 2023, performing 50,000 procedures in the first year.
• Olympus released disposable ablation probes in 2024, cutting infection risks by 30%.
• AngioDynamics launched a hybrid ablation system in 2025, integrating radiofrequency and microwave, now adopted by 300 hospitals globally.

Report Coverage of Thermal Ablation Devices Market

The Thermal Ablation Devices Market Report provides in-depth coverage of key market dynamics, segmentation, competitive landscape, and regional performance. It includes analysis of more than 50 global manufacturers, evaluating market share, product launches, and adoption rates. The report examines trends across oncology, cardiology, and gynecology, with over 14 million annual ablation procedures globally as a reference point.

Segmentation analysis covers device types such as radiofrequency, microwave, hydrothermal, interstitial, and needle probes, accounting for varying shares from 6% to 45%. The report further categorizes applications across hospitals, ASCs, and clinics, highlighting hospitals as the leading end-users with 52% market share.

Regional coverage includes North America, Europe, Asia-Pacific, and Middle East & Africa, with detailed breakdowns of prevalence, procedure volumes, and adoption rates. North America leads with 41% market share, followed by Europe at 29%, Asia-Pacific at 23%, and Middle East & Africa at 7%.

Additionally, the Thermal Ablation Devices Industry Report highlights technological innovations such as AI, robotics, and disposable probes, covering 36% of product launches since 2023. The market outlook emphasizes growth opportunities, challenges, and competitive strategies shaping future adoption.

Thermal Ablation Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 4701.73 Million in 2026
Market Size Value By	USD 10916.21 Million by 2035
Growth Rate	CAGR of 9.81% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Interstitial Probes Grounded Probes Needle Applications Radiofrequency Ablation Hydrothermal Ablation Microwave Ablation By Application : Hospitals Ambulatory Surgical Centers (ASCs) Clinics
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample